Form4insider filings, from the source

SEC Form 4 · accession 0001651308-18-000018

BeOne Medicines Ltd. · ONC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Amy C. Peterson
Officer — CMO, Immuno-oncology
Period of report
Dec 17, 2018
Accepted (ET)
Dec 19, 2018 · 6:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651308

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
American Depositary SharesF1,F2Dec 17, 2018M9,859$29.10A9,859D
American Depositary SharesF1,F4Dec 17, 2018S900$130.3678D8,959D
American Depositary SharesF1,F5Dec 17, 2018S2,700$131.7972D6,259D
American Depositary SharesF1,F6Dec 17, 2018S1,700$132.9137D4,559D
American Depositary SharesF1,F7Dec 17, 2018S1,005$133.8095D3,554D
American Depositary SharesF1,F8Dec 17, 2018S778$135.0446D2,776D
American Depositary SharesF1,F9Dec 17, 2018S2,296$136.2446D480D
American Depositary SharesF1,F10Dec 17, 2018S480$136.93D0D
American Depositary SharesF1,F2Dec 18, 2018M10,141$29.10A10,141D
American Depositary SharesF1,F11Dec 18, 2018S1,631$131.735D8,510D
American Depositary SharesF1,F12Dec 18, 2018S1,897$132.7018D6,613D
American Depositary SharesF1,F13Dec 18, 2018S2,402$133.8822D4,211D
American Depositary SharesF1,F14Dec 18, 2018S3,600$134.8099D611D
American Depositary SharesF1,F15Dec 18, 2018S611$135.5422D0D
Ordinary Sharesholding———194,569D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Share Option (Right to Buy)F16,F17$2.24Dec 17, 2018M128,167D—Aug 21, 2026Ordinary Shares128,167951,833D
Share Option (Right to Buy)F16,F17$2.24Dec 18, 2018M131,833D—Aug 21, 2026Ordinary Shares131,833820,000D

Explanation of responses